Shafey, G. M., E. R. Rashed, H. F. Zaki, A. S. Attia, and M. A. El-Ghazaly, "Molecular mechanisms involved in the effects of morin in experimental hepatic encephalopathy", Biofactors, vol. 48, pp. 1166–1178., 2022. morin_paper_final.pdf
Shalaby, H. N., H. F. Zaki, A. A. A. Ain‑Shoka, and R. A. Mohammed, "Adenosine A2A Receptor Blockade Ameliorates Mania Like Symptoms in Rats: Signaling to PKC‑α and Akt/GSK‑3β/β‑Catenin", Molecular Neurobiology, vol. 59, pp. 6397–6410, 2022. adenosine_final.pdf
Saber, M. M., N. Monir, A. S. Awad, M. E. Elsherbiny, and H. F. Zaki, "TLR9: A friend or a foe", Life Sciences, vol. 307, pp. 120874, 2022. tlr-9_review.pdf
Monir, N., M. M. Saber, A. S. Awad, M. E. Elsherbiny, and H. F. Zaki, "Repression of inflammatory pathways with Boswellia for alleviation of liver injury after renal ischemia reperfusion ", Life Sciences, vol. 306, pp. 120799, 2022. bosweillia_final.pdf
Mansour, S. M., S. Aly, S. H. M. Hassan, and H. F. Zaki, "Protective effect of sitagliptin and whole-body c-irradiation in diabetes-induced cardiac injury", Canadian Journal of Physiology and Pharmacology, vol. 99, pp. 676–684, 2021.
Badawi, G. A., M. M. Shokr, H. F. Zaki, and A. F. Mohamed, "Pentoxifylline prevents epileptic seizure via modulating HMGB1/RAGE/TLR4 signalling pathway and improves memory in pentylenetetrazol kindling rats", Clinical and Experimental Pharmacology and Physiology. , vol. 48, issue 8, pp. 1111–1124, 2021. pentoxyfilline_final.pdf